1. Home
  2. GKOS vs AROC Comparison

GKOS vs AROC Comparison

Compare GKOS & AROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • AROC
  • Stock Information
  • Founded
  • GKOS 1998
  • AROC 1990
  • Country
  • GKOS United States
  • AROC United States
  • Employees
  • GKOS N/A
  • AROC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • AROC Oil & Gas Production
  • Sector
  • GKOS Health Care
  • AROC Energy
  • Exchange
  • GKOS Nasdaq
  • AROC Nasdaq
  • Market Cap
  • GKOS 5.4B
  • AROC 4.5B
  • IPO Year
  • GKOS 2015
  • AROC 1997
  • Fundamental
  • Price
  • GKOS $91.09
  • AROC $24.66
  • Analyst Decision
  • GKOS Strong Buy
  • AROC Buy
  • Analyst Count
  • GKOS 13
  • AROC 6
  • Target Price
  • GKOS $122.08
  • AROC $31.50
  • AVG Volume (30 Days)
  • GKOS 1.6M
  • AROC 1.9M
  • Earning Date
  • GKOS 10-29-2025
  • AROC 10-28-2025
  • Dividend Yield
  • GKOS N/A
  • AROC 3.36%
  • EPS Growth
  • GKOS N/A
  • AROC 65.71
  • EPS
  • GKOS N/A
  • AROC 1.50
  • Revenue
  • GKOS $469,820,000.00
  • AROC $1,439,161,000.00
  • Revenue This Year
  • GKOS $30.89
  • AROC $31.39
  • Revenue Next Year
  • GKOS $24.36
  • AROC $6.57
  • P/E Ratio
  • GKOS N/A
  • AROC $16.61
  • Revenue Growth
  • GKOS 30.38
  • AROC 31.94
  • 52 Week Low
  • GKOS $73.16
  • AROC $20.12
  • 52 Week High
  • GKOS $163.71
  • AROC $30.44
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 60.41
  • AROC 47.24
  • Support Level
  • GKOS $80.91
  • AROC $24.23
  • Resistance Level
  • GKOS $102.80
  • AROC $25.29
  • Average True Range (ATR)
  • GKOS 4.63
  • AROC 0.78
  • MACD
  • GKOS 1.07
  • AROC -0.06
  • Stochastic Oscillator
  • GKOS 56.85
  • AROC 26.22

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About AROC Archrock Inc.

Archrock Inc is an energy infrastructure company with a focus on midstream natural gas compression and a commitment to helping customers produce, compress, and transport natural gas. It has two business segments, Contract Operations, and Aftermarket Services. Under the umbrella of contract operations services, the company provides operations to meet customers' natural gas compression needs. Services include designing, owning, installing, operating, and maintaining equipment. Aftermarket Services business provides a full range of services to support the compression needs of customers who own compression equipment, including operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components. It generates maximum revenue from the Contract Operations segment.

Share on Social Networks: